Dynavax Technologies Corporation (DVAX)
- Exchange
- NASDAQ
- Symbol
- DVAX
- Sector
- Life Sciences
- Industry
- Pharmaceutical Preparations
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company is headquartered in Emeryville, California.
- Country
- USA
Stock price
At close: November 6, 2024
-
Open12.25
-
High12.41
-
Low12.00
-
Close12.29
-
Volume3,241,680
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
3.85
Receivables turnover
—
Payables turnover
39.13
Working capital turnover
0.30
Days of inventory on hand (DOH)
94.77
Days of sales outstanding (DSO)
—
Number of days of payables
9.33
Fixed asset turnover
6.30
Total asset turnover
0.24
Current ratio
13.81
Quick ratio
11.74
Cash ratio
11.94
Cash conversion cycle
85.44
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.60
Interest coverage
0.36
Gross profit margin
12.70%
Operating profit margin
-15.75%
Pretax margin
-1.84%
Net profit margin
-2.72%
Operating return on assets (Operating ROA)
-3.71%
Return on assets (ROA)
-0.64%
Return on total capital
0.39%
Return on equity (ROE)
-1.03%